121 related articles for article (PubMed ID: 7514791)
1. Effect of L-364,718 (CCK receptor antagonist) on exocrine pancreatic secretion of hydrocortisone-treated rats.
De Dios I; Manso MA
Pancreas; 1994 Mar; 9(2):212-8. PubMed ID: 7514791
[TBL] [Abstract][Full Text] [Related]
2. Effect of L-364,718 (CCK receptor antagonist) on exocrine pancreatic secretion of adrenalectomized rats.
Manso MA; De Dios I
Pancreas; 1993 May; 8(3):362-7. PubMed ID: 8483879
[TBL] [Abstract][Full Text] [Related]
3. Long-term blockade of cholecystokinin (CCK): effects of L 364,718 (a CCK receptor antagonist) on pancreatic enzyme storage and secretion.
Rodriguez AI; Manso MA; Garcia-Montero AC; Orfao A; de Dios I
Pancreas; 1997 Oct; 15(3):314-22. PubMed ID: 9336798
[TBL] [Abstract][Full Text] [Related]
4. Action of CCK on CDE diet-induced acute pancreatitis in rats treated with hydrocortisone.
Manso MA; Rebollo A; Pescador R; de Dios I
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Jun; 111(2):257-63. PubMed ID: 8521247
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of the inhibitory effect of FK480, a CCK-A receptor antagonist, on pancreatic exocrine secretion by achlorhydria.
Kuno M; Sogabe H; Ito H; Matsuo T; Satoh Y; Motoyama Y; Tanaka H
Pancreas; 1998 Jul; 17(1):57-64. PubMed ID: 9667521
[TBL] [Abstract][Full Text] [Related]
6. Effect of a novel cholecystokinin receptor antagonist, FK480, administered intraduodenally, on pancreatic secretion in rats.
Moriyoshi Y; Shiratori K; Takeuchi T; Watanabe S
Pancreas; 1995 Apr; 10(3):295-300. PubMed ID: 7542771
[TBL] [Abstract][Full Text] [Related]
7. Time-course of the pancreatic changes following long-term stimulation or inhibition of the CCK-A receptor.
Ohlsson B; Axelson J; Sternby B; Rehfeld JF; Ihse I
Int J Pancreatol; 1995 Aug; 18(1):59-66. PubMed ID: 7594771
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic administration of hydrocortisone on the induction and evolution of acute pancreatitis induced by cerulein.
Pescador R; Manso MA; Rebollo AJ; de Dios I
Pancreas; 1995 Aug; 11(2):165-72. PubMed ID: 7479674
[TBL] [Abstract][Full Text] [Related]
9. Chronic administration of a potent cholecystokinin receptor antagonist, L-364,718, fails to inhibit pancreas growth in preweanling rats.
Wisner JR; Ozawa S; Xue BG; Renner IG
Pancreas; 1990 Jul; 5(4):434-8. PubMed ID: 1696382
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
[TBL] [Abstract][Full Text] [Related]
11. Total parenteral nutrition affects the tropic effect of cholecystokinin on the exocrine pancreas.
Fan BG; Axelson J; Sternby B; Rehfeld J; Ihse I; Ekelund M
Scand J Gastroenterol; 1997 Apr; 32(4):380-6. PubMed ID: 9140162
[TBL] [Abstract][Full Text] [Related]
12. Effects of L-364,718 on pancreatic exocrine and endocrine secretion in the rat.
Nakamura T; Fujii M; Okabayashi Y; Tani S; Fujisawa T; Koide M; Otsuki M
Pancreas; 1990 Mar; 5(2):216-21. PubMed ID: 1690422
[TBL] [Abstract][Full Text] [Related]
13. Duration of anti-cholecystokinin (CCK) action on the rat exocrine pancreas of new CCK receptor antagonist FK480 administered orally.
Moriyoshi Y; Shiratori K; Iwabe C; Watanabe S; Takeuchi T
J Gastroenterol; 1996 Apr; 31(2):249-53. PubMed ID: 8680546
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a new diphenylpyrazolidinone cholecystokinin antagonist in vitro isolated rat pancreatic acini.
Akiyama T; Tachibana I; Otsuki M
Int J Pancreatol; 1993 Oct; 14(2):167-73. PubMed ID: 7506744
[TBL] [Abstract][Full Text] [Related]
15. Effects of a new benzodiazepine derivative cholecystokinin receptor antagonist FK480 on pancreatic exocrine secretion in anesthetized rats.
Tachibana I; Otsuki M
Dig Dis Sci; 1994 Jun; 39(6):1321-8. PubMed ID: 8200267
[TBL] [Abstract][Full Text] [Related]
16. Dose-related involvement of CCK in bombesin-induced pancreatic growth.
Liehr RM; Reidelberger RD; Rosewicz S; Bussjaeger LJ; Solomon TE
Regul Pept; 1992 Apr; 38(3):207-19. PubMed ID: 1375383
[TBL] [Abstract][Full Text] [Related]
17. Effect of L364718 on interdigestive pancreatic exocrine secretion and gastroduodenal motility in conscious sheep.
Onaga T; Mineo H; Kato S
Regul Pept; 1997 Jan; 68(2):139-46. PubMed ID: 9110386
[TBL] [Abstract][Full Text] [Related]
18. Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonist.
Pendleton RG; Bendesky RJ; Schaffer L; Nolan TE; Gould RJ; Clineschmidt BV
J Pharmacol Exp Ther; 1987 Apr; 241(1):110-6. PubMed ID: 2437283
[TBL] [Abstract][Full Text] [Related]
19. Exocrine pancreatic response to CCK in rats after long-term hydrocortisone administration.
Manso MA; De Dios I; San Roman JI; Martin M; Lopez MA
Peptides; 1990; 11(2):237-42. PubMed ID: 2356155
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of receptors for gastrin, cholecystokinin and GRP/bombesin in postprandial stimulation of exocrine pancreas in dogs.
Konturek SJ; Tasler J; Bilski J; Cieszkowski M; Cai RZ; Schally AV
J Physiol Pharmacol; 1993 Mar; 44(1):43-53. PubMed ID: 8390873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
